Finnissy: Piano Concertos 4 and 6; Snowdrift; To and Fro; Verdi Transcriptions (Complete)by Ian Pace; Michael Finnissy
- 期刊名称Tempo (New Series)
- 作者Review by: John Warnaby
- 期第220期
- 印刷ISSN0040-2982
- 电子ISSN1478-2286
- 文件大小223.97KB
- 发表时间2002-04
- DOI10.2307/946604
- 页码56-57
Anin vitromodel for the development of acquired tamoxifen resistanceGuney Eskiler, Gamze; Cecener, Gulsah; Tunca, Berrin; Egeli, Unal · Cell Biology and Toxicology · 2016
Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancerGuney Eskiler, Gamze; Cecener, Gulsah; Dikmen, Gokhan; Egeli, Unal; Tunca, Berrin · European Journal of Pharmaceutical Sciences · 2018
Talazoparib nanoparticles for overcoming multidrug resistance in tripleânegative breast cancerGuney Eskiler, Gamze; Cecener, Gulsah; Egeli, Unal; Tunca, Berrin · Journal of Cellular Physiology · 2020
Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitroEskiler, Gamze Guney; Cecener, Gulsah; Dikmen, Gokhan; Egeli, Unal; Tunca, Berrin · Current Drug Delivery · 2019
Potential role of solid lipid nanoparticles in overcoming the acquired tamoxifen resistance of breast cancerCecener, Gulsah; Eskiler, Gamze Guney; Egeli, Unal; Tunca, Berrin · Journal of Biotechnology · 2017
BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profileGuney Eskiler, Gamze; Cecener, Gulsah; Egeli, Unal; Tunca, Berrin · Journal of Biochemical and Molecular Toxicology · 2019
Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acidYurdacan, Beste; Egeli, Unal; Guney Eskiler, Gamze; Eryilmaz, Isil Ezgi; Cecener, Gulsah; Tunca, Berrin · Journal of Pharmacy and Pharmacology · 2019